XML 11 R4.htm IDEA: XBRL DOCUMENT v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Operating expenses:        
Research and development (including non-cash stock-based compensation expense of $0.9 million and $0.6 million for three months ended June 30, 2026 and 2025, respectively and $1.8 million and $1.1 million for six months ended June 30, 2026 and 2025 respectively) $ 24,619 $ 13,409 $ 46,049 $ 23,944
General and administrative (including non-cash stock-based compensation expense of $36.0 million and $1.2 million for the three months ended June 30, 2026 and 2025, respectively and $37.6 million and $2.3 million for six months ended June 30, 2026 and 2025 respectively 41,189 5,061 47,302 10,711
Total operating expenses 65,808 18,470 93,351 34,655
Loss from operations (65,808) (18,470) (93,351) (34,655)
Other income (expense), net        
Interest income, net 3,257 2,976 5,390 6,076
Research and development tax credit 236 610 803 610
Other expense, net (34) (59) (80) (68)
Total other income, net 3,459 3,527 6,113 6,618
Loss before income taxes (62,349) (14,943) (87,238) (28,037)
Income tax provision 251 134 770 165
Net loss (62,600) (15,077) (88,008) (28,202)
Other comprehensive income (loss), net of tax:        
Foreign currency translation adjustment 18 (3) 33 (3)
Unrealized (loss) gain on available-for-sale securities (557) (59) (809) 133
Comprehensive loss $ (63,139) $ (15,139) $ (88,784) $ (28,072)
Net loss per share, basic $ (1.78) $ (6.4) $ (4.6) $ (12.05)
Net loss per share, diluted $ (1.78) $ (6.4) $ (4.6) $ (12.05)
Weighted-average common shares outstanding, basic 35,236,214 2,356,777 19,118,049 2,340,431
Weighted-average common shares outstanding, diluted 35,236,214 2,356,777 19,118,049 2,340,431